Search This Blog

Tuesday, April 9, 2019

Chimerix beefs up management team

Chimerix (NASDAQ:CMRX) announces following appointments:
Michael A. Sherman, former CEO of Endocyte, appointed as CEO of Chimerix, effective immediately.
Michael T. Andriole, former CFO of Endocyte, appointed to the newly created position of Chief Business Officer.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)